Document is current
Any future updates will be listed below
-
Authors
Ferrer, Ricard
Luque, Sonia
Martínez-Martínez, Luis
de Lossada, Alfonso
Maroto-Diaz, Marta
Moya-Alarcón, Carlota
de Ceano-Vivas, Maria Carmen
Moreno, Yolanda
Dennis, James
Nikolova, Silviya
Zormpas, Evangelos
Broughton, Edward
Gheorghe, Maria
-
Funding
Funding for this research was provided by:
Pfizer Inc
- License Information
-
More Information
Article History
Received: 20 May 2025
Accepted: 15 July 2025
First Online: 28 July 2025
Declarations
:
: Ricard Ferrer has received fees as a speaker from Pfizer, MSD, Shionogi, Gilead, GE, AOP Health, Grifols, Thermo Fisher, Estor, Toray, BD, Menarini, and Sobi. Sonia Luque has participated in educational programs organized by MSD, Pfizer, Advanz, Menarini and Shionogi. Luis Martínez-Martínez has participated in educational programs organized by MSD, Pfizer and Shionogi and has conducted research studies financed by Janssen, MSD, Pfizer, Advanz and Shionogi. Edward Broughton and Maria Gheorghe are employees of Pfizer Inc. Alfonso de Lossada, Marta Maroto-Diaz, Carlota Moya-Alarcón, Maria Carmen de Ceano-Vivas, Yolanda Moreno are employees of Pfizer SLU. James Dennis, Silviya Nikolova and Evangelos Zormpas are employees of Health Economics and Outcomes Research Ltd. Health Economics and Outcomes Research Ltd. received fees from Pfizer Inc. in relation to this study.
: This article is based on a model and does not contain any new studies with human participants or animals performed by any of the authors.
